[{"internal_id": 139744506, "Award ID": "U01IP001160", "Award Amount": 3117126.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-08-25", "CFDA Number": "93.083", "Description": "COLLABORATIVE RESEARCH ON INFLUENZA, CORONAVIRUS DISEASE 2019 (COVID-19), AND OTHER RESPIRATORY PATHOGENS IN SOUTH AFRICA", "Place of Performance Country Code": "ZAF", "Place of Performance State Code": null, "COVID-19 Obligations": 1717126.0, "Infrastructure Obligations": null, "recipient_id": "2bed8b66-147f-ed1e-d798-428cde4059ce-C", "generated_internal_id": "ASST_NON_U01IP001160_7523"}, {"internal_id": 69725195, "Award ID": "U01IP001106", "Award Amount": 3538495.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-20", "CFDA Number": "93.083", "Description": "PUBLIC HEALTH EPIDEMIOLOGY OF INFLUENZA VIRUS INFECTION AND CONTROL IN CHINA", "Place of Performance Country Code": "CHN", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f5f9df7d-d2f2-84ad-9694-5ff033f12d2b-C", "generated_internal_id": "ASST_NON_U01IP001106_7523"}, {"internal_id": 50095340, "Award ID": "U01IP001073", "Award Amount": 1499255.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-07-19", "CFDA Number": "93.083", "Description": "IMPACT OF AFIX AND PHYSICIAN-TO-PHYSICIAN ENGAGEMENT ON HPV VACCINATION IN PRIMARY CARE: AN RCT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f371179b-9f27-8013-f81c-4fd314b1f981-C", "generated_internal_id": "ASST_NON_U01IP001073_7523"}, {"internal_id": 50095338, "Award ID": "U01IP001064", "Award Amount": 10399559.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-07-14", "CFDA Number": "93.083", "Description": "RESEARCH ON THE EPIDEMIOLOGY, VACCINE EFFECTIVENESS AND TREATMENT OF INFLUENZA AND OTHER RESPIRATORY VIRUSES IN SOUTHEAST ASIA AND THE WESTERN PACIFI", "Place of Performance Country Code": "CHN", "Place of Performance State Code": null, "COVID-19 Obligations": 400000.0, "Infrastructure Obligations": null, "recipient_id": "3e4f580d-624e-6941-a78c-3ce575a6876b-C", "generated_internal_id": "ASST_NON_U01IP001064_7523"}, {"internal_id": 50095324, "Award ID": "U01IP000979", "Award Amount": 3759057.67, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-28", "CFDA Number": "93.083", "Description": "DETERMINING INFLUENZA VACCINE EFFECTIVENESS (DIVE)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": 339235.07, "Infrastructure Obligations": null, "recipient_id": "af8e08af-9f61-5dc4-b13f-32b17f32dc92-C", "generated_internal_id": "ASST_NON_U01IP000979_7523"}, {"internal_id": 50095323, "Award ID": "U01IP000974", "Award Amount": 4467078.39, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-28", "CFDA Number": "93.083", "Description": "US HOSPITAL VACCINE EFFECTIVENESS (VE) NETWORK", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": 499999.0, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_U01IP000974_7523"}, {"internal_id": 50095322, "Award ID": "U01IP000972", "Award Amount": 2980763.79, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-28", "CFDA Number": "93.083", "Description": "CORE_APT MEASURE OF PCR-BASED INFLUENZA VACCINE EFFECTIVENESS IN INPATIENT ADULTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": 354212.03, "Infrastructure Obligations": null, "recipient_id": "10e96899-6f49-cf1c-3362-f53a22ddb44c-C", "generated_internal_id": "ASST_NON_U01IP000972_7523"}, {"internal_id": 50095321, "Award ID": "U01IP000969", "Award Amount": 4462574.62, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-28", "CFDA Number": "93.083", "Description": "FLU VACCINE EFFECTIVENESS IN THOSE HOSPITALIZED IN A LARGE DIVERSE HEALTH SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": 491412.94, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_U01IP000969_7523"}, {"internal_id": 50095320, "Award ID": "U01IP000965", "Award Amount": 899336.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-08-12", "CFDA Number": "93.083", "Description": "JOINT INITIATIVE IN VACCINE ECONOMICS 5", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_U01IP000965_7523"}, {"internal_id": 50095318, "Award ID": "U01IP000848", "Award Amount": 4230101.47, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2014-07-31", "CFDA Number": "93.083", "Description": "EPIDEMIOLOGY, PREVENTION, AND TREATMENT OF INFLUENZA AND OTHER RESPIRATORY INFECT", "Place of Performance Country Code": "GBR", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5651cbe0-315c-112a-2f04-7b1b5248cfad-C", "generated_internal_id": "ASST_NON_U01IP000848_7523"}, {"internal_id": 151948281, "Award ID": "R43IP001195", "Award Amount": 252010.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-09-01", "CFDA Number": "93.083", "Description": "MRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": 252010.0, "Infrastructure Obligations": null, "recipient_id": "bfca5dd5-6c9f-4bb4-f1c8-d61aa9c4b3e4-R", "generated_internal_id": "ASST_NON_R43IP001195_7523"}, {"internal_id": 139742601, "Award ID": "R43IP001168", "Award Amount": 243000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-08-30", "CFDA Number": "93.083", "Description": "IDENTIFICATION OF SERODIAGNOSTIC EPITOPES FOR SARS-COV-2, ENDEMIC HCOV?S AND INFLUENZA VIRUS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "76179491-01b9-bee4-1fbf-8e68478a9824-C", "generated_internal_id": "ASST_NON_R43IP001168_7523"}, {"internal_id": 140058438, "Award ID": "R43IP001167", "Award Amount": 243000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-09-10", "CFDA Number": "93.083", "Description": "A TOTALLY SYNTHETIC IMMUNOSTIMULATOR THAT TARGETS TOLL-LIKE RECEPTOR 2 AND NOD2: TOWARD IMPROVED INFLUENZA VACCINES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "846f96a2-ad4e-e852-1ac1-e395d3146d1e-C", "generated_internal_id": "ASST_NON_R43IP001167_7523"}, {"internal_id": 140059571, "Award ID": "R43IP001166", "Award Amount": 243000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-09-10", "CFDA Number": "93.083", "Description": "DEVELOPMENT OF ANTIGEN-BASED VERTICAL FLOW ASSAY FOR THE RAPID DETECTION OF SARS-COV-2, INFLUENZA A/B, AND RSV", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0fe6981e-21d3-29bc-14d7-fc31e8b4e8b6-C", "generated_internal_id": "ASST_NON_R43IP001166_7523"}, {"internal_id": 140059659, "Award ID": "R43IP001164", "Award Amount": 243000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-09-08", "CFDA Number": "93.083", "Description": "ADJUVANTED RECOMBINANT CANDIDATES TO PRIME / BOOST COVID-19 RNA VACCINES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "10c063d3-4089-21c5-8d15-176ce7f6b40c-C", "generated_internal_id": "ASST_NON_R43IP001164_7523"}, {"internal_id": 140059481, "Award ID": "R43IP001163", "Award Amount": 242132.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-09-08", "CFDA Number": "93.083", "Description": "RAPID SARS-COV-2 SPIKE PROTEIN NEUTRALIZING ANTIBODY TESTS FOR EVALUATING COVID VACCINE-GENERATED IMMUNITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "181c73a5-ec81-8420-9e07-c8ba7cb298d6-R", "generated_internal_id": "ASST_NON_R43IP001163_7523"}, {"internal_id": 49819997, "Award ID": "R43IP001085", "Award Amount": 214693.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-28", "CFDA Number": "93.083", "Description": "DIRECT SEQUENCING OF ANTIBODIES OF THE INFLUENZA IMMUNE RESPONSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4f1fb6c4-c787-fe5c-c54b-647a97fb46d0-C", "generated_internal_id": "ASST_NON_R43IP001085_7523"}, {"internal_id": 49819996, "Award ID": "R43IP000846", "Award Amount": 150000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-09-24", "CFDA Number": "93.083", "Description": "A RAPID, BLOOD RNA ASSAY FOR THE DIAGNOSIS OF ACUTE RESPIRATORY INFECTIONS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "264729d9-0989-8b5f-69c3-e059d27f25cc-C", "generated_internal_id": "ASST_NON_R43IP000846_7523"}, {"internal_id": 140057376, "Award ID": "NH23IP922656", "Award Amount": 40398809.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-09-13", "CFDA Number": "93.083", "Description": "CDC-RFA-IP21-2111 IMPROVING ADULT IMMUNIZATION RATES FOR COVID-19 INFLUENZA, AN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": 30475000.0, "Infrastructure Obligations": null, "recipient_id": "8913d9aa-c0eb-ced4-8298-af49e8b76040-R", "generated_internal_id": "ASST_NON_NH23IP922656_7523"}, {"internal_id": 140058125, "Award ID": "NH23IP922655", "Award Amount": 7060456.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-09-09", "CFDA Number": "93.083", "Description": "CDC-RFA-IP21-2111 IMPROVING ADULT IMMUNIZATION RATES FOR COVID-19 INFLUENZA, AN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": 5633744.0, "Infrastructure Obligations": null, "recipient_id": "4a425638-3232-b6ea-4c1e-67de4eddb51c-C", "generated_internal_id": "ASST_NON_NH23IP922655_7523"}]